A citation-based method for searching scientific literature

Rui Batista, Adriana Cruvinel-Carloni, João Vinagre, Joana Peixoto, Telmo A Catarino, Nathalia Cristina Campanella, Weder Menezes, Aline Paixão Becker, Gisele Caravina de Almeida, Marcus M Matsushita, Carlos Clara, Luciano Neder, Marta Viana-Pereira, Mrinalini Honavar, Lígia Castro, José Manuel Lopes, Bruno Carvalho, Rui Manuel Vaz, Valdemar Máximo, Paula Soares, Manuel Sobrinho-Simões, Rui Manuel Reis, Jorge Lima. Int J Cancer 2016
Times Cited: 36



Sabine Spiegl-Kreinecker, Daniela Lötsch, Bahil Ghanim, Christine Pirker, Thomas Mohr, Magdalena Laaber, Serge Weis, Alfred Olschowski, Gerald Webersinke, Josef Pichler, Walter Berger. Neuro Oncol 2015
Times Cited: 69




List of shared articles



Times cited

TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Nathalie Olympios, Vianney Gilard, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Maxime Fontanilles. Cancers (Basel) 2021
0

Telomere Maintenance Mechanisms in Cancer.
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares, João Vinagre. Genes (Basel) 2018
43

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.
Sabine Spiegl-Kreinecker, Daniela Lötsch, Katharina Neumayer, Lucia Kastler, Johannes Gojo, Christine Pirker, Josef Pichler, Serge Weis, Rajiv Kumar, Gerald Webersinke,[...]. Neuro Oncol 2018
37

Human TERT promoter mutations as a prognostic biomarker in glioma.
Branka Powter, Sarah A Jeffreys, Heena Sareen, Adam Cooper, Daniel Brungs, Joseph Po, Tara Roberts, Eng-Siew Koh, Kieran F Scott, Mila Sajinovic,[...]. J Cancer Res Clin Oncol 2021
0

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.
Muhammad Khairul Ramlee, Jing Wang, Wei Xun Toh, Shang Li. Genes (Basel) 2016
70

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma.
Pauline Blateau, Etienne Coyaud, Estelle Laurent, Benoit Béganton, Vincent Ducros, Géraldine Chauchard, Julie A Vendrell, Jérôme Solassol. Cancers (Basel) 2020
2

Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis.
Na Shen, Yanjun Lu, Xiong Wang, Jing Peng, Yaowu Zhu, Liming Cheng. Oncotarget 2017
13

When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.
Saumya R Bollam, Michael E Berens, Harshil D Dhruv. Curr Neurol Neurosci Rep 2018
3

TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients.
Paola Del Bianco, Camilla Stagni, Silvia Giunco, Alessio Fabozzi, Lisa Elefanti, Stefania Pellegrini, Antonella Vecchiato, Jacopo Pigozzo, Carolina Zamuner, Anita De Rossi,[...]. Cancers (Basel) 2020
5

TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data.
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, Hanh T T Ngo, Thong Quang Pham, Aden Ka-Yin Chan, Chul-Kee Park, Kar-Ming Fung, Lewis Hassell. Crit Rev Oncol Hematol 2017
22

TERT promoter mutations in telomere biology.
Barbara Heidenreich, Rajiv Kumar. Mutat Res Rev Mutat Res 2017
76

The Solo Play of TERT Promoter Mutations.
François Hafezi, Danielle Perez Bercoff. Cells 2020
8